Results · Apr-Jun 2026 · filed 12 Aug 2026
Bacil Pharma Q1 FY27 results
Sales were ₹0 crore against ₹0 crore in Apr-Jun 2025.
Net profit turned into a loss of ₹0.02 crore, from a profit of ₹0.67 crore in Apr-Jun 2025.
Against Jan-Mar 2026: swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.0 | 0.0 | n/m |
| Operating profit (EBITDA) | -0.0 | -0.1 | n/m |
| Net profit | -0.0 | 0.7 | swings to a loss |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 8 quarters
Filings that week
- 17 Aug 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th August 2026
- 12 Aug 2026Un-Audited Financial Results For The Quarter Ended 30Th June, 2026
- 12 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.